JP2025506186A5 - - Google Patents

Info

Publication number
JP2025506186A5
JP2025506186A5 JP2024547694A JP2024547694A JP2025506186A5 JP 2025506186 A5 JP2025506186 A5 JP 2025506186A5 JP 2024547694 A JP2024547694 A JP 2024547694A JP 2024547694 A JP2024547694 A JP 2024547694A JP 2025506186 A5 JP2025506186 A5 JP 2025506186A5
Authority
JP
Japan
Prior art keywords
optionally substituted
hydrogen
substituted
unsubstituted
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024547694A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506186A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/062436 external-priority patent/WO2023154896A2/en
Publication of JP2025506186A publication Critical patent/JP2025506186A/ja
Publication of JP2025506186A5 publication Critical patent/JP2025506186A5/ja
Pending legal-status Critical Current

Links

JP2024547694A 2022-02-11 2023-02-10 Trkbリガンドコンジュゲート化合物及びその使用 Pending JP2025506186A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202263309337P 2022-02-11 2022-02-11
US63/309,337 2022-02-11
US202263327342P 2022-04-04 2022-04-04
US63/327,342 2022-04-04
US202263335150P 2022-04-26 2022-04-26
US63/335,150 2022-04-26
US202263352809P 2022-06-16 2022-06-16
US63/352,809 2022-06-16
PCT/US2023/062436 WO2023154896A2 (en) 2022-02-11 2023-02-10 Trkb ligand conjugated compounds and uses thereof

Publications (2)

Publication Number Publication Date
JP2025506186A JP2025506186A (ja) 2025-03-07
JP2025506186A5 true JP2025506186A5 (cg-RX-API-DMAC10.html) 2026-02-18

Family

ID=87565161

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024547694A Pending JP2025506186A (ja) 2022-02-11 2023-02-10 Trkbリガンドコンジュゲート化合物及びその使用

Country Status (9)

Country Link
US (1) US20250161459A1 (cg-RX-API-DMAC10.html)
EP (1) EP4475837A2 (cg-RX-API-DMAC10.html)
JP (1) JP2025506186A (cg-RX-API-DMAC10.html)
KR (1) KR20240159828A (cg-RX-API-DMAC10.html)
AU (1) AU2023218398A1 (cg-RX-API-DMAC10.html)
CA (1) CA3251455A1 (cg-RX-API-DMAC10.html)
IL (1) IL314847A (cg-RX-API-DMAC10.html)
MX (1) MX2024009892A (cg-RX-API-DMAC10.html)
WO (1) WO2023154896A2 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4698652A2 (en) * 2023-04-20 2026-02-25 Adarx Pharmaceuticals, Inc. Mapt-modulating compositions and methods of use thereof
WO2025038971A1 (en) * 2023-08-17 2025-02-20 Adarx Pharmaceuticals, Inc. Oligonucleotides containing a ligand at a nucleobase, 2' position, or 3' position
AU2025211114A1 (en) * 2024-01-24 2026-06-18 F. Hoffmann-La Roche Ag Linkers for site-specific protein conjugation
WO2026057077A1 (zh) * 2024-09-14 2026-03-19 厦门甘宝利生物医药有限公司 一种多靶点rna抑制剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0381902A1 (en) * 1989-01-09 1990-08-16 Merrell Dow Pharmaceuticals Inc. Tetralin derivatives
US7166755B2 (en) * 2004-09-30 2007-01-23 Air Products And Chemicals, Inc. Synthesis of pentafluorosulfanylnaphthalene

Similar Documents

Publication Publication Date Title
JP2728148B2 (ja) アミノアルギニンの分離および身体内の酸化窒素生成を遮断するための用途
JPH08503940A (ja) 酵素阻害薬
JP2003502339A (ja) プリン誘導体
HRP20000904A2 (en) Farnesyl protein transferase inhibitors for treating arthropathies
JPH0629186B2 (ja) 抗低酸素および虚血薬理組成物
JPH07509219A (ja) H↓3受容体アンタゴニストとしての4−[4’−ピペリジニルまたは3’−ピロリジニル]置換イミダゾールおよび治療上のその使用方法
JPH02290841A (ja) 新規化合物、その製法及びそれを含む医薬組成物
JPS636058B2 (cg-RX-API-DMAC10.html)
JP2000510129A (ja) ジスタマイシン誘導体、その調製方法並びに抗腫瘍薬及び抗ウイルス薬としてのその使用
KR0130977B1 (ko) 항종양제로서 폴리아민 유도체
RU2441875C2 (ru) Терапевтические соединения
HUT64553A (en) A process for preparing anti-viral and anti-tumouric 2'-desoxi-2',2'-difluorine-(2,6,8-substituted)-purine-nucleosides and pharmaceutical compositions comprising them as active ingredient
JPH09508382A (ja) K−チャネル遮断薬用シアノグアニジン類
US20040092536A1 (en) Neurologically active compounds and compounds with multiple activities
WO2025153624A1 (en) Imidazo[1,2-d][1,2,4]triazine derivatives for use as inhibitors of the nlrp3 inflammasome pathway
JPH08512279A (ja) 抗サイトメガロウイルス剤としてのポリアミン誘導体類
JP3773148B2 (ja) 虚血性疾患予防、治療剤及び臓器保存剤
WO2023072292A1 (zh) 一种高效抗病毒化合物及其用途
JP3025557B2 (ja) 2‐アルキニルアデノシン誘導体
JP2000503986A (ja) Hiv―1陽性であるヒトにおけるデラビルジンおよびプロテアーゼ・インヒビターの使用
DE69520876T2 (de) Gamma-diketonverbindung mit thrombozytenaggregationshemmender wirkung
JP3094450B2 (ja) 神経保護特性を有するピペリジン誘導体
JP2815691B2 (ja) Krn2391酸付加塩およびその用途
JPH03291261A (ja) ω−アミノ−フェニルアルカノニトリル誘導体
JPH0859688A (ja) 5’−チオノエステル置換トリフルオロチミジン誘導体およびそれを有効成分とする制癌剤